SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Perficient, Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - May 13, 2024) - Rigrodsky Law, P.A. is investigating Perficient, Inc. ("Perficient") (NASDAQ: PRFT) regarding possible breaches of fiduciary duties and other vi

newsfileMay 14 04:30

Alliance Global Partners: Downgraded Perfusion (PRFT.US) rating from buy to neutral.

Alliance Global Partners: Downgraded Perfusion (PRFT.US) rating from buy to neutral.

Zhitong FinanceMay 8 01:01

Alliance Global Partners Downgrades Perficient to Neutral

Alliance Global Partners analyst Brian Kinstlinger downgrades Perficient from Buy to Neutral.

Analyst UpgradesMay 8 00:56

Perficient Cut to Hold From Buy by Maxim Group

Perficient Cut to Hold From Buy by Maxim Group

Dow JonesMay 7 23:53

Maxim Group: Downgraded Perfusion (PRFT.US) rating from buy to hold, with a target price of $76.00.

Maxim Group: Downgraded Perfusion (PRFT.US) rating from buy to hold, with a target price of $76.00.

Zhitong FinanceMay 7 23:50

Maxim Group Downgrades Perficient to Hold, Announces $76 Price Target

Maxim Group analyst Jack Vander Aarde downgrades Perficient from Buy to Hold and announces $76 price target.

Analyst UpgradesMay 7 23:43